First AD

Second AD

Birtamimab in AL Amyloidosis: Key Takeaways from the Phase III VITAL Trial

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Insights Video Series

The Evolving Treatment Landscape in Light Chain Amyloidosis with Cardiac Involvement

Drs. Kumar and Zonder discuss results from the Phase III Vital trial investigating birtamimab and key takeaways.

AL Amyloidosis: Background, Patient Profile, and Staging

Navigating the Differential Diagnosis of AL Amyloidosis

Treatment Approaches in AL Amyloidosis 

Limitations of Available Treatment Options for Patients with Cardiac Involvement 

Birtamimab Safety Profile in the VITAL Study

Adverse Event Management in AL Amyloidosis

Ongoing AFFIRM-AL Trial Background, Patient Eligibility, and Active Enrollment

Revolutionizing the AL Amyloidosis Treatment Paradigm: Novel Agents and Combination Approaches

Clinical Pearls and Future Directions in AL Amyloidosis